About Author : Mateen Dalal


Mateen Dalal

Despite working as a professional testing engineer, Mateen Dalal always held a liking for content creation. Following his passion, he now pens down articles for itresearchbrief.com and a couple of similar portals. Mateen is a qualified electronics and telecommunication engineer and strives to combine his technical expertise with his interest in his articles.



Contribution by: Mateen Dalal

Enlitic partners with Select Healthcare for early cancer detection

Artificial Intelligence in healthcare industry is set to be one of the highest revenues generating markets in the future due to the extraordinary benefits offered by this integrated system to the patients. Thus, collaborations between artificial inte...


Read More >>
Harley-Davidson pulls the plug from its electric motorcycle production

For years, American motorcycle manufacturer Harley Davidson has been ruling the biking industry. It was one of major motorcycle firms that survived the great depression of the 1930s. However, with the advent of electric mobility worldwide, the motorc...


Read More >>
Advaxis announces revised survival data in Phase 1/2 ADXS-PSA Trial

Drugs used for the treatment of various diseases are only made available in the market after confirmation of its safety and efficacy in patients enrolled in its clinical trials. Clinical studies indicate possibility of better outcomes for a given tre...


Read More >>
Convergint Technologies acquires Real Connect to expand in Europe

Service based system integration firms are witnessing a substantial growth recently due to the integration benefits in quality and productivity of operations. Pertaining to the rapid industry growth and integration advancements, investment in the sys...


Read More >>
Entos signs research and development agreement with anonymous partner

There is a substantial growth in the number of inflammatory and autoimmune diseases cases. Various firms across the world are increasingly working towards the development and discovery of drugs that can effectively treat these diseases. To significan...


Read More >>
Kadimastem Announces Positive Results from Phase 1/2a Trial for ALS

Amyotrophic Lateral Sclerosis (ALS) is a progressive fatal neurodegenerative disease which causes low functionality in lower and upper motor nerves that control muscle function. It causes muscle weakness, paralysis, breathing problems and could event...


Read More >>
Lumina Networks launches next-gen Intent Based Automation Solution

Industries nowadays are looking to maximize their business infrastructure in a bid to fulfill demands on safety, productivity, performance optimization and equipment availability. This growing demand has led several automation service providers to de...


Read More >>
HP announces acquisition of end-point security startup Bromium

In today’s digital and interconnected world, the need for creating a safe and secure digital environment holds of a paramount importance. Technology security has become a vital issue which requires strict attention. Numerous organizations in th...


Read More >>
FarmWise raises $14.5 million for sustainable farming robot systems

With the advent of technological advancements in the agricultural sector, farmers are now trying to address issues such as equipment management and crop care using robots. Numerous agri-tech companies are raising investments to develop cutting edge s...


Read More >>
Kura Oncology conducts Phase 1 trial of KO-539 for treating AML

With each passing day, new technologies are enabling researchers to develop therapeutic drugs that can help aid mankind. Because of innovative technologies and research, there is an availability for treatments targeting numerous diseases. Biopharmace...


Read More >>
Nexstar gets FCC nod on $6.4 billion acquisition of Tribune Media

Whether watching your favorite TV series or seeking the latest news updates, local television stations have long been an integral part of people’s lives across the globe. With growing subscribers, service providers and companies have started to...


Read More >>
New York governor bans all flavored e-cigarettes in a vaping crackdown

Gov. Cuomo announced the ban on flavored e-cigarettes to address the growing cases of vaping related health illnesses and deaths among youths. An emergency action could go into effect within two weeks, banning all flavors of tobacco and menthol. ...


Read More >>
Toyota plans to use same batteries as Tesla for China plug-in hybrids

·    The automaker is using batteries designed by Panasonic for Levin and Corolla hybrid sedans for the Chinese market.  ·    The move will help Toyota secure high-quality batteries as well as boost th...


Read More >>
Sanofi pays $260Mn to terminate its partnership with Lexicon

The announcement resulted in a sudden surge of Lexicon’s shares, which went up by 37.8% to $2.37 in after-hours trading. France-based multinational pharma conglomerate Sanofi SA, is reportedly liable to pay a sum of $260 million to Lexicon Pha...


Read More >>
Accenture acquires Pragsis Bidoop to strengthen technology expertise

The company plans to expand its technology expertise to help clients scale their AI capabilities and accelerate data-driven model.   Pragsis Bidoop will play a vital role in strengthening Accenture’s Applied Intelligence unit. Global...


Read More >>
Patriot One buys XTRACT Tech to augment PATSCAN Platform capabilities

Patriot One is thrilled to integrate a highly talented team join its ranks since they share the company’s vision for building a world that is safe from mass violence. XTRACT team will bring with it leading-edge expertise in machine learning ...


Read More >>
Lupin and Boehringer Ingelheim join hands to develop anti-cancer drug

The 2 major companies have inked a deal valued at USD 700 million for the development of the cancer drug.   Lupin to receive royalty on the sales of the drug developed while retaining the commercial rights to the program in India. Multinat...


Read More >>
Rambus to acquire Secure Protocols & Silicon IP business of Verimatrix

Verimatrix and Rambus plan to enter an asset purchase agreement after placing certain pre-conditions.   The deal would allow the company to expand its global reach and deliver security solutions worldwide. Rambus Inc., a prime silicon IP a...


Read More >>
Boehringer Ingelheim, Zealand initiate Phase 2 pilot of BI 456906

The German pharma company aims to initiate its phase II trial for BI456906 in late 2019, paying a sum of €20 million to Zealand Pharma A/S. Boehringer Ingelheim, a pharmaceutical company based out of Germany, and Zealand Pharma A/S, a biotechno...


Read More >>
ZTE paves its way back to US smartphone market with Axon 10 Pro

Chinese manufacturer launches Axon 10 Pro in the US following imposed penalty few years ago. Axon 10 Pro is claimed to be driven by Qualcomm's Snapdragon 855 octa-core chipset. Chinese smartphone manufacturer, ZTE has reportedly marked its r...


Read More >>
American fitness startup Peloton files for an Initial Public Offering

The startup has recorded annual revenue of $915 million and hopes to raise at least $500 million from its IPO. Peloton, a U.S.-based fitness startup that produces exercise equipment has reportedly submitted its paperwork for an initial public o...


Read More >>
ThredUP receives $175M in funding, will use capital to expand platform

US-based online clothing resale store, ThredUP announced having received $175 million in funding which will be invested for the expansion of its online resale services to the retailers. The total capital raised by the company now goes beyond $300 mil...


Read More >>
FDA authorizes antibiotic for community-acquired bacterial pneumonia

Xenleta (lefamulin) will be given Priority Review by FDA to act over its application in a quicker time frame.   The Food and Drug Administration approved Xenleta to Nabriva Therapeutics.     The Food and Drug Administr...


Read More >>
FDA approves oncology drug that targets cancer with NTRK gene fusion

The approval includes an indication for pediatric patients over 12 years of age with NTRK-fusion-positive tumors based on information obtained primarily in adults. The U.S. Food and Drug Administration has recently granted approval to an oncology dr...


Read More >>
Amazon to acquire 10% stake in household retailer Future Retail

Amazon plans to expand its reach in the Indian market in a bid to compete with Walmart owned Flipkart. Amazon Inc., a multinational tech company based in Seattle, has recently announced that it is about to close a deal to acquire Future Retail Ltd....


Read More >>
KKR forms alliance with NVC Lighting, acquires share in NVC China

The resources and operational expertise of KKR supports NVC Lighting’s China Lighting business for sustained growth in the domestic market.   The alliance between the 2 companies will benefit NVC Lighting with 30 per cent of NVC China....


Read More >>
IMT FA to launch in Asian markets as factory automation supplier

The factory automation supplier is set to launch its brand in the Asian markets by 2019. The company has attained patents and certifications related to the machine automation essentials for smart factory systems. South Korea based IMT FA, which ...


Read More >>
Eureka Therapeutics initiates phase 1/2 trials of ET140202 ARTEMIS™

The Phase 1/2 study is a clinical trial of ET140202 ARTEMIS™ T-Cell therapy for the treatment of progressive hepatocellular carcinoma (HCC), one of the major types of liver cancer. Eureka Therapeutics, Inc., a biopharmaceutical firm focus...


Read More >>
Translate Bio unveils interim results for MRT5005 in cystic fibrosis

MRT5005 has been designed to address the primary cause of cystic fibrosis (CF) irrespective of genetic mutation Reports confirm that Translate Bio, an mRNA therapeutics company, has recently announced the interim results from a first-in-human Phase ...


Read More >>
Minut earns USD 8 million for camera-less home security device

The series A funding of Minut raised $8 million. The added advantage offered is home monitoring with no hinderance to individual privacy of people living there. A Swedish startup company formed in 2014, Minut has reportedly developed a camera-le...


Read More >>
Bio-Rad wins motion against rival 10X Genomics in district court

The court has allowed 10X Genomics to sell products for use with already sold systems, subject to royalty payment. Bio-Rad Laboratories Inc., a manufacturer of clinical diagnostic products and life science research, has recently announced that the D...


Read More >>
Compass takes over ROOT to enter Montreal Data Center Market

Texas headquartered Compass Datacenters has declared the acquisition of the Montreal based ROOT Data Center in order to expand its portfolio into the Montreal Hyperscale data center market. The deal follows days after Compass Datacenter’s annou...


Read More >>
Amazon plans to build fulfillment centers in Akron & Rossford, Ohio

The company’s new fulfillment center would generate around 2,500 full-time jobs in Ohio.         Amazon.com, Inc., an American technological company, has recently announced its plans to build two new ro...


Read More >>
Skyhawk signs pact with Genentech to develop oncology treatments

Skyhawk Therapeutics, Inc., a drug discovery and development company, has recently announced that it has entered into an agreement with Genentech, a Roche Group member, to commercialize and develop small molecules that modulate RNA splicing.  A...


Read More >>
Gilead Sciences invests in Galapagos to expand drug R&D capabilities

Gilead will gain exclusive access to all of the existing and upcoming compounds in Galapagos’ pipeline Foster City, California-headquartered drug maker Gilead Sciences is reportedly in talks to increase its share in Belgian-Dutch biotechnology...


Read More >>
CNOOC, Sinopec ink cooperation agreement to study offshore blocks

Both parties have reportedly signed three joint study agreement under the framework CNOOC Limited, the largest crude oil and natural gas producer in China, recently announced that it has signed a Corporation Framework Agreement with Sinopec Corp. ( ...


Read More >>
OntarioMD adds 12 north west Ontario hospitals into HRM solution

OntarioMD, a company specializing in the selection, implementation and adoption of electronic medical records (EMR) and provincial digital health tools, recently announced that it will be adding 12 hospitals in north west Ontario to its provincial&nb...


Read More >>
Auris Medical completes enrollment of Phase 1b trial of AM-201

AM-201 is an investigating drug being developed for the prevention of antipsychotic drug induced weight gain and somnolence. Auris Medical Ltd. – a biopharmaceutical company has reportedly completed the enrollment of its phase 1b proof-of-con...


Read More >>
Hemostemix CLI trial abstract accepted for presentation by CSVS

Hemostemix Inc., a Canada-based biotechnology company recently announced that its CLI (critical limb ischemia) trial abstract has been accepted to be presented at the 41st Annual Meeting of Canadian Society for Vascular Surgery. For the record,...


Read More >>
NGL Energy confirms Mesquite acquisition, secures investment form EIG

Combining the assets of Mesquite will create Delaware Basin’s largest water disposal system NGL Energy Partners LP, a diverse midstream MLP providing several services to end-users and producers, recently announced that it has completed its acq...


Read More >>
Speech recognition AI startup Uniphore targets $38m in Series C round

Uniphore is anticipated to be valued at $130 million by the end of the current round Uniphore Software Systems, a Chennai-headquartered speech recognition solutions company, is reportedly in talks for a $38 million Series C funding round led by Marc...


Read More >>
Flight Centre fortifies European footprint with acquisition of 3Mundi

Flight Centre Travel Group, an Australia-based travel agency has recently announced that it has acquired 3Mundi, a Paris-based corporate travel group. The acquisition has brought around $275 million in TTV, under Flight Centre’s global authorit...


Read More >>
Translate Bio gets FDA nod for Phase 1/2 trial in OTC deficient adults

The trial is a significant milestone for the company as it advances a second mRNA therapeutic targeting a genetic disease into clinical development Translate Bio, an mRNA therapeutics company that develops transformative medicines for treating disea...


Read More >>
Krystal announces positive results from GEM-2 study of KB103

The pharmaceutical company received Regenerative Medicine Advanced Therapy designation from FDA for KB103 Krystal Biotech, Inc., a gene therapy company recently announced positive results from a Phase 2 clinical trial of KB103 (the GEM 2 study) and ...


Read More >>
PHASTAR and Medidata unveil technology partnership for data services

The partnership is aimed at transforming biotech and pharmaceutical sector to safely bring new healthcare options to patients Global CRO PHASTAR and Medidata Solutions Inc. have reportedly unveiled their brand-new technology partnership. The former ...


Read More >>
Dr Reddy’s introduces medicinal equivalent of Vitamin K1 in US market

Dr. Reddy’s Laboratories Ltd., an India-based multinational pharmaceutical company, recently announced the launch of a therapeutic equivalent generic version of Phytonadione (Vitamin K1), Phytonadione Injectable Emulsion USP. The drug has ...


Read More >>
DiaMedica unveils interim results from Phase 1b study of DM199 in CKD

The trial’s interim results met the expectations of the primary endpoints that include safety, tolerability and PK Clinical-stage biotech company, DiaMedica Therapeutics Inc, recently announced the interim results of Phase 1b study of DM199, a...


Read More >>
Blue Prism advances its cloud strategy by acquiring Thoughtonomy

Blue Prism, a UK based multinational software company, recently declared to acquire UK-headquartered fast-growing technology company, Thoughtonomy. The buyout is likely to close by July 2019, claim sources. The integration of this AI technology comp...


Read More >>
Nexen Tire partners with Plug and Play for future tech development

The partnership was announced at Plug & Play’s headquarter in Sunnyvale, California Nexen Tire, a leading tire manufacturer, recently announced that it has entered into a partnership with US-based Plug & Play, an early stage investor a...


Read More >>
Celyad unveils clinical update on CYAD-01 trial for relapsed AML, MDS

Celyad, a biopharmaceutical company focused on the advancement of CAR-T cell therapies, has confirmed updated clinical data for the CYAD-01 program in r/r AML and MDS, presented through a poster presentation session on June 15, 2019 in Amsterdam, Net...


Read More >>
Sunesis presents Vecabrutinib trial data at the EHA annual meeting

The Phase 1b/2 clinical trial assessed the efficacies of vecabrutinib in patients suffering from CLL & other B-Cell related malignancies. The preliminary data reported at the EHA meeting was from over 23 patients that were treated in the clini...


Read More >>
Endonovo to launch opioid alternative SofPulse® across U.S. hospitals

The company expects to generate more than $300 million in sales by 2020 Endonovo Therapeutics, a commercial-stage developer of non-invasive medical devices that are designed to deliver its proprietary Electroceutical therapy, recently announced its ...


Read More >>
Concert Pharma’s CTP-692 displays favorable results in Phase 1 Studies

Concert Pharmaceuticals, Inc., a clinical biopharmaceutical company, reportedly announced positive outcomes from two studies in its Phase 1 program assessing the effects of CTP-692, a novel deuterium-modified form of D-serine being created as an adju...


Read More >>
Biogen to unveil new data on biosimilar anti-TNF portfolio at EULAR’19

Data to be presented at the European Congress of Rheumatology will confirm the efficacy and safety of the anti-TNF biosimilars and high adherence of patients who are being treated Biogen, a multinational biotechnology company, recently announced tha...


Read More >>
Medtronic initiates pivotal trial for MiniMed™ 780G AHCL system

The next-gen system is designed to automate correction boluses delivery when a user experiences, or is likely to experience, prolonged high glucose levels. Renowned medical device company, Medtronic plc has recently announced the enrollment of initi...


Read More >>
Goldfinch Bio instigates Phase 1 trial of GFB-887 for Kidney Disease

Goldfinch Bio, Inc., a biotechnology firm developing precision therapies for kidney disease patients, has reportedly started dosing in its Phase 1 clinical trial assessing GFB-887. The firm’s selective and sub-type specific small molecule TRPC5...


Read More >>
Amazon’s Prime delivery air drone to go operational in a few months

The e-commerce giant claims its drone’s safety features to be as robust and stable as a commercial aircraft. Global e-commerce giant, Amazon has recently unveiled the latest version of its Prime Air delivery drone, claiming that it aims to lau...


Read More >>
Minoryx Therapeutics begins its Leriglitazone phase-2 clinical trial

· A patient participating in the clinical trial has already been dosed with the company’s lead candidate, leriglitazone. · The patient was given the dose at Hospital La Paz in Madrid by a clinical team led by Dr. Francisco Javier...


Read More >>
Thermo Fisher, Newomics ink disease biomarker validation partnership

The companies will look to develop and optimize microflow LC-MS solutions which could advance the understanding and diagnosis of complex diseases Leading biotechnology company Thermo Fisher Scientific has recently confirmed it will collaborate with ...


Read More >>
BioTheryX bags FDA approval for acute myeloid leukemia treatment drug

The company expects enrollment of Phase I Trial during the third quarter of 2019. U.S. biotechnology firm, BioTheryX, Inc. has recently announced that the the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IN...


Read More >>
NetApp, NVIDIA join forces to develop AI Centre of Excellence in India

It will help partners and customers who are looking for AI deployment as a part of their transformation journey NVIDIA, the graphics processing unit designer and NetApp, a data management service provider, have reportedly announced a partnership to ...


Read More >>
BioMarin’s hemophilia gene therapy seeks approval in U.S & Europe

BioMarin Pharmaceutical Inc.’s experimental gene therapy, valoctocogene roxaparvovec, targeting severe hemophilia A in adults has reportedly met pre-specified clinical criteria to seek regulatory review in the U.S. and Europe.  According ...


Read More >>
Victory Metals initiates Phase II drill program at Iron Point Project

The program will include drilling 49 holes using one diamond drill rig and two reverse circulation (RC) rigs. Vancouver-based Victory Metals Inc. has recently announced the launch of a 10,000-metre drilling program at its Iron Point Vanadium Project...


Read More >>
Reprieve Cardiovascular reveals late-breaking AHF clinical trial data

The trials were set to determine the Reprieve-Guided Diuretic Therapy system’s ability to achieve safe net volume reduction while alleviating related symptoms in ADHF patients. Reprieve Cardiovascular™, one of the leading medical device ...


Read More >>
AzurRx’s Phase II OPTION study of MS1819-SD achieves enrollment target

It has reached the enrollment target of 30-35 patients that was determined when the OPTION study was started in December 2018 AzurRx BioPharma has recently confirmed that it has achieved its enrollment target of 30-35 patients in the ongoing Phase I...


Read More >>
Lilly’s low-cost insulin lispro hits shelves despite price disputes

Pharmaceutical major Eli Lilly has officially launched an inexpensive generic version of the insulin drug Humalog, reports of which made way to the headlines in March. If sources are to be believed, the launch has come on the heels of the outrageous ...


Read More >>
Tocagen continues with Toca 5 Phase 3 trial in brain cancer patients

The trial is being conducted in patients with recurrent high-grade glioma An Independent Data Monitoring Committee recommended the study continue without modification Reports confirm that Tocagen Inc, a clinical-stage and cancer-selective gene ther...


Read More >>
Coatue Management to lead $120 million funding in Rebel Foods

Faasos involves delivery-only restaurants and brands which helps it to save on real estate costs. The capital markets company Coatue Management will reportedly lead a $120 million funding round in food on demand company Rebel Foods, popular for its ...


Read More >>
QIAGEN & Inovio team up to develop diagnostic for cervical dysplasia

QIAGEN has been bringing its extensive track record of commercially creating and marketing novel diagnostic tests to the collaboration. QIAGEN N.V. and Inovio Pharmaceuticals Inc. have reportedly announced that both the companies have collabora...


Read More >>
Tata Sky collaborates with Amazon to introduce OTT aggregator service

Currently the company is looking at 66 cities across India and eventually the service will be available countrywide Reports confirm that Amazon and Tata Sky have recently introduced over the top (OTT) aggregator service called ‘Tata Sky Binge&...


Read More >>
Tata Communications, Cisco extend partnership for new SD-WAN offering

The partnership will focus on allowing enterprises to transform their existing legacy network into a customized and more secure multi-cloud native hybrid network. Indian telecom conglomerate, Tata Communications has recently extended its partnershi...


Read More >>
Intel and Cray team up to build a $500m exascale supercomputer by 2021

The two companies are developing the Aurora program, with a goal of putting together an exascale computing system for U.S. DOE’s Argonne National Laboratory Intel and Cray have recently announced that the two companies are developing the Auror...


Read More >>
PTT Exploration & Production PLC selects VALLOUREC for supplying OCTG

Thailand-based PTT Exploration and Production PLC has reportedly selected Vallourec to provide oil country tubular goods for a demanding offshore project situated in Myanmar. In a recent turn of events, PTTEP, Thailand's national oil manufact...


Read More >>
Google plans to close down its immersive film unit Spotlight Stories

The studio would close now after making stories for more than six years and putting them in VR, on screens and on phones   Permanent employees of the Spotlight Stories are expected to be offered other roles within Google Google has recentl...


Read More >>
Two Blue Cross Blue Shield insurers combine with Oregon’s Cambia

Both the companies would reportedly merge the administrative, operational, and corporate management services under the brand name Cambia Health Solutions Insurance operators Blue Cross and Blue Shield of North Carolina have recently declared that th...


Read More >>
US insists Germany drop Huaweis equipment from its 5G infrastructure

Germany has been urged to bar equipment provided by Huawei and other Chinese manufacturers This would be the first time U.S. is threatening a country against consequences for using Huawei equipment Reportedly, a letter from U.S. Ambassador Richa...


Read More >>
Roches Tecentriq® gets U.S. FDA nod for patients with breast cancer

The cancer immunotherapy drug could significantly reduce the risk of disease worsening or death (PFS) in patients by 40%. Swiss healthcare conglomerate, Roche AG has recently announced that the U.S. FDA (Food and Drug Administration) has granted app...


Read More >>
ASLAN, BioGenetics ink deal to commercialize AML therapy in S. Korea

ASLAN would grant BioGenetics exclusive rights for commercializing ASLAN003 in South Korea The therapy showed early signs of efficacy and safety in refractory and relapsed AML patients Clinical-stage oncology-focused biopharmaceutical firm, ASLA...


Read More >>
Suven enters new purchase agreement to acquire Rising Pharma assets

Suven has entered the asset purchase agreement through its JV partner, Shore Suven Pharma, Inc.   Following the deal’s announcement Suven Life shares went up by 0.45%, trading at approximately INR 268 apiece. Suven Life Sciences Ltd....


Read More >>
Softbank launches $5B fund for Latin America’s technology landscape

The fund will be used to pour in capital for the development of technology startups in Latin America.   The fund’s location for headquarters remains undecided so far. Japanese holding conglomerate Softbank has apparently made it to t...


Read More >>
Johnson & Johnson’s Spravato gets FDA approval for treating depression

The drug is aimed at patients with severe depression who have shown resistance to two antidepressants they have tried. The U.S. Food & Drug Administration (FDA) has recently granted approval for Spravato, the ketamine-derived nasal spray develop...


Read More >>